Alfresa Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARHCF research report →
Price Chart
About the company
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies.
- CEO
- Ryuji Arakawa
- IPO
- 2007
- Employees
- 12,525
- HQ
- Tokyo, SA, JP
Get TickerSpark's AI analysis on ARHCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $2.46B
- P/E
- 10.93
- Fwd P/E
- 0.11
- PEG
- 0.19
- P/S
- 0.13
- P/B
- 0.83
- EV/EBITDA
- 3.44
- Div Yield
- 2.97%
- Gross Margin
- 6.91%
- Op Margin
- 1.04%
- Net Margin
- 1.22%
- ROE
- 7.76%
- ROIC
- 3.94%
Latest fiscal year · YoY change
- Revenue
- $3.12T+5.5%
- Gross Profit
- $219.25B+2.5%
- Op Income
- $36.25B
- Net Income
- $42.01B+53.4%
- EPS
- $231.68+57.0%
- OCF Growth
- +588.2%
- FCF Growth
- +211.9%
- 52W High
- $14.59
- 52W Low
- $11.87
- 50D MA
- $14.00
- 200D MA
- $12.71
- Beta
- 0.08
- RSI (14)
- 80
- Avg Volume
- 1.25K
No earnings-call transcripts are available for ARHCF yet.
- Free Float
- 80.8%
- Shares Outstanding
- 175.42M
- Float Shares
- 141.67M
Our ARHCF coverage
Recent articles, reports, and earnings notes.
No research on ARHCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARHCF report →